Is the decrease of AVR (arterovenous ratio)in patients with severe OSAS, reversible after long term use of CPAP?

R. Bossi, C. Carnevale Carlino, F. M. Massari, C. Vecchiato (Italy)

Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Bossi, C. Carnevale Carlino, F. M. Massari, C. Vecchiato (Italy). Is the decrease of AVR (arterovenous ratio)in patients with severe OSAS, reversible after long term use of CPAP?. Eur Respir J 2010; 36: Suppl. 54, 912

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Mild OSAS: Is CPAP therapy actually required for these patients?
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Is obstructive sleep apnoea common in patients undergoing bariatric surgery and, if so, should perioperative bi-level positive airway pressure treatment be considered?
Source: Eur Respir J 2007; 30: Suppl. 51, 321s
Year: 2007

CPAP treatment for sleep apnea syndrome: compliance increases with very long term use
Source: Eur Respir J 2005; 26: Suppl. 49, 723s
Year: 2005

CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 412s
Year: 2006

Compliance for NIMV treatment in moderate and severe OSAS patients
Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology
Year: 2012

Are there any patient-features to predict long-term benefit from noninvasive intermittent positive pressure ventilation (nIPPV) in patients with severe stable chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 403s
Year: 2001

The reversibility of hypoxemia in OSA patients is related to CPAP therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 112s
Year: 2005

Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006


Predictive factors for stopping use of continuous positive airway pressure (CPAP): an observational cohort of 6938 treated obstructive sleep apnea syndrome (OSAS) patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Effects of 1 year of treatment with nocturnal CPAP in overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

The use of the cyclical sigh function in long term non-invasive ventilation (NIV) as a method of lung volume recruitment to control hypercapnia in a patient with severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications
Year: 2016


Nocturnal oxygen therapy (NOT) versus nasal ventilation with Auto-CS in patients with severe chronic heart failure (CHF) and Cheyne-Stokes respiration (CSR): a long-term study over 2 years
Source: Eur Respir J 2002; 20: Suppl. 38, 9s
Year: 2002

Antiarrhythmic effect of CPAP and uvulopalatopharyngoplasty (UPPP) in patients with severe OSAS
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008



CPAP treatment reduce blood pressure in patients with recent diagnosis of systemic hypertension and obstructive sleep apnoea -hypopnoea (OSAH). A controlled study
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008


The impact of long-term conventional treatment for overlap syndrome (OSA and COPD) on concurrent erectile dysfuction (ED)
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006

Long-term continuous positive airway pressure (nCPAP) treatment maintains the improvement of insulin sensitivity in patients with OSAS after 2.8 years
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Long term effects of CPAP in blood pressure in nonsleepy hypertensive OSA patients
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008

The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Long term effect of nasal positive -pressure ventilation on sleep architecture in patients with staple chronic respiratory failure
Source: Eur Respir J 2002; 20: Suppl. 38, 623s
Year: 2002